People receiving chemotherapy not only suffer from side effects of therapeutics but also must buy expensive drugs. Targeted drug and gene delivery directed to specific tumor-cells is one way to reduce the side effect of drugs and use less amount of therapeutics. In this research, two novel liposomal nanocarriers were developed. This nanocarrier, called an eLiposome, is basically one or more emulsion droplets inside a liposome. Emulsion droplets are made of perfluorocarbons which usually have a high vapor pressure. Calcein (as a model drug) and Paclitaxel were used to demonstrate drug delivery, and plasmids and siRNA were used to exemplify gene delivery. Drugs or genes were encapsulated inside the interior of the liposomes along with emulsion droplets; targeting moieties were attached to the outside of the phospholipid bilayer. Ultrasound was used to break open the bilayer by changing the liquid emulsion droplets to gas, which released the content of the eLiposomes. Transmission electron microscopy (TEM) was used to prove the formation of eLiposomes and confocal microscopy showed the uptake of drugs and genes in vitro. Cell viability was measured to show the effect of uptake in cancer cells. Results indicate that eLiposomes were successfully made and that they were endocytosed into the cell. It was observed that the emulsion and the targeting moiety in combination with ultrasound are the essential elements required to produce release from eLiposomes.

Ultra-thin films (UTFs) are important in many applications, seen in the semiconductor industry, in chromatography, in sensing, in microfluidics, in aerospace, and in robotics. They also protect materials from corrosion, change surface energies, limit water intrusion into materials, allow material self-cleaning and self-healing, provide scratch resistance, and impart other specific chemical properties. In many cases, UTFs drastically alter surface properties and therefore their applications. It is imperative that proper and consistent characterization be performed on coatings to confirm and understand their desired properties. In Chapter two, Al oxidation under MgF2 protective layers is studied using real time X-ray photoelectron spectroscopy (XPS), and spectroscopic ellipsometry (SE). These tools allowed me to monitor Al oxidation for both short (hours) and long (months) periods of time. XPS revealed the chemical changes that took place in these materials as a function of time, and these changes were verified with SE. These studies help increase an understanding of aluminum changes under MgF2 protective layers. The third chapter demonstrates ab initio calculations guided X-ray photoelectron spectroscopy (XPS) analysis of surfaces functionalized with fluorinated silanes. This study addresses deficiencies in the literature where CF2:CF3 ratios from experimental XPS data do not match theoretical CF2:CF3 ratios. In a systematic approach, I developed semi-empirical models directed both by ab initio calculations and adjustable, empirical parameters. These models were effective in describing the raw data and exceeded fitting methods used in literature. In Chapter four, SiO2 UTFs with variable thicknesses deposited on Eagle XG® glass substrates are characterized. Challenges associated with this work consisted of similar optical functions of the film and substrate as well as backside reflections from the substrate. These obstacles were met using a multi-sample analysis (MSA), a variable angle spectroscopic ellipsometric approach, and mechanical abrasion/roughening of the substrate backside. With these approaches, I developed a model that precisely fit the data collected from all the samples and gave the correct optical function of the material along with thickness values for each film. Surface characterization represents a commitment of resources. It takes time to make measurements, and it takes time to analyze and understand the results. As presented in this work, I increase understanding of ultra-thin films at interfaces using both a multi-tool approach as well as using multiple analytical methods on data collected from each tool.

Peritoneale Verwachsungen sind die häufigste Komplikation nach operativen Eingriffen. Sie haben abdominelle Beschwerden, chronische Ileuszustände und den akuten Ileus zur Folge. Diese peritonealen Reaktionen sind bei Neugeborenen und Säuglingen besonders ausgeprägt. Seit es operative abdominelle Eingriffe gibt, stellt das Vermeiden von peritonealen Adhäsionen ein zentrales Problem dar. Eine Vielzahl von Substanzen, lokal oder systemisch angewendet, wurde getestet, um Adhäsionen zu vermeiden. Bis heute hat sich kein gesicherter Standard für die Sekundärprophylaxe von Adhäsionen etabliert. Eine nicht ausreichende Wirksamkeit oder klinisch nicht akzeptable Nebenwirkungen sind dafür die Ursache. Das primäre Vermeiden von Verwachsungen steht nach wie vor im Mittelpunkt chirurgischer Bemühungen. Das organschonende Operieren und das Verbannen von Talkum an den Handschuhen der Chirurgen sind weltweit anerkannte Maßnahmen der Primärprophylaxe von Adhäsionen. Dass man auch den Abrieb von Bauchtüchern, die üblicherweise aus Baumwolle gefertigt sind, für die Entstehung von Adhäsionen verantwortlich machen muss, ist seit langem bekannt, wurde aber bisher in der operativen Praxis weitestgehend ignoriert. Die vorliegende tierexperimentelle Arbeit am Rattenmodell zeigt, dass die Verwendung alternativer Werkstoffe (Polyestergewebe) anstelle der üblichen Baumwolltücher zu einer deutlichen Verminderung der Adhäsionszahl und -stärke führt. Im zweiten Teil der Arbeit wird gezeigt, dass neben diesen primärprophylaktischen Maßnahmen auch sekundär Adhäsionen reduziert werden können. Wir untersuchten hierzu die Wirkung von PF 5080, einem Perfluorcarbon, auf das Peritoneum. Eine deutliche Reduktion der postoperativen Verwachsungen am Rattenmodell ließ sich nachweisen. Die lokale und systemische Wirkungsweise dieser Substanz ist noch weitgehend unbekannt und bedarf weiterer Forschung. / Peritoneal adhesions are the most common complication after surgical procedures. They often cause abdominal pain and bowel obstruction. Those peritoneal reactions are very intense in newborn and infants. Since the first days of open abdominal surgery the avoidance of adhesions has been a key problem. A countless array of drugs for local or systemic use to reduce adhesions has been tested. Until now no proven standard of secondary prophylaxis against adhesions has been established. The reasons are inefficiency or unacceptable side effects. The primary avoidance of adhesions is still the main focus for surgeons. Surgical techniques which keeps the organ carefully and the banishment of talcum from surgical gloves are widely acknowledged standards in the primary prophylaxis of adhesions. The fact that cotton particles from surgical swabs also contribute to postoperative adhesions has been known for along time but until now ignored in surgical practice. This study shows that the use of alternative material like polyester instead of cotton during operation does strongly reduce the formation of adhesions in rat. A further finding of this study is that the instillation of PF 5080, a Perfluorocarbon, in the late phase of the operation in the abdominal cavity does also reduce postoperative adhesions in rat. The local and systemic mode of function remains unknown and will be the subject to further research.

O transplante de ilhotas microencapsuladas constitui uma alternativa terapêutica interessante para o Diabetes Mellitus tipo 1, permitindo um melhor controle glicêmico e eliminando a necessidade de imunossupressão. Entretanto, a manutenção a longo prazo da viabilidade das células-&#946; ainda é um desafio. No isolamento, a perda da matriz extracelular e as condições hipóxicas subsequentes afetam decisivamente a sobrevivência e funcionalidade das ilhotas. Objetivo Para diminuir o estresse sobre o enxerto, levando a um sucesso prolongado do transplante, propôs-se a adição de perfluorocarbono (PFC) ou laminina (LN), moléculas associadas respectivamente à oxigenação e interações célula-célula, ao biomaterial baseado em alginato, Biodritina, adequado ao encapsulamento celular. Metodologia Para testar a estabilidade das formulações PFC-Biodritina e LN-Biodritina, microcápsulas foram submetidas a diferentes estresses (rotacional, osmótico, temperatura e cultura) por 7 e 30 dias. A pureza do biomaterial foi avaliada pela coincubação com macrófagos murinos RAW264.7, por 3, 9 e 24h, quando a ativação dos macrófagos foi observada pela expressão gênica de IL- 1&#946; e TNF&#945;. Microcápsulas implantadas i.p. em camundongos foram recuperadas após 7 ou 30 dias, para análises de biocompatibilidade. A expressão de níveis de mRNA (bax, bad, bcl-2, bcl-XL, xiap, caspase 3, mcp1/ccl2, hsp70, ldh, insulina 1 e 2), proteínas (Bax, Bcl-XL e Xiap) e a atividade de Caspase3 foram avaliadas em ilhotas microencapsuladas com PFC- e LN-Biodritina, após cultura de 48h em condições de normóxia e hipóxia (<2% O2). Camundongos diabéticos foram transplantados com ilhotas encapsuladas nas diferentes formulações e os animais foram monitorados pelas variações de massa corporal, glicêmicas e pela funcionalidade do enxerto (TOTGs). As ilhotas foram recuperadas de animais normo ou hiperglicêmicos e uma análise de biocompatibilidade das cápsulas foi realizada, assim como a avaliação funcional das células-&#946;. Após o explante, a glicemia dos animais normoglicêmicos foi monitorada para se atestar a eficiência das ilhotas transplantadas. Resultados Microcápsulas de PFC- e LN-Biodritina são tão estáveis e biocompatíveis quanto as de Biodritina. Para ilhotas encapsuladas em ambos os materiais, em normóxia ou hipóxia, observou-se uma modulação gênica que sugere proteção contra apoptose. Adicionalmente, encontrou-se uma diminuição na expressão de genes indicadores de estresse (mcp1, hsp70). Uma diminuição nos níveis de mRNA de ldh foi vista para PFC-Biodritina, mas o oposto foi encontrado para LN-Biodritina. As diferenças encontradas na expressão proteica sugerem o mesmo padrão anti-apoptótico. Caspase3 não foi modulada por nenhum biomaterial. Nos experimentos de transplante, apenas LN-Biodritina levou reversão prolongada do diabetes, com 60% dos animais normoglicêmicos, 198 dias pós-cirurgia, comparado a 9% do grupo Biodritina. O TOTG demonstrou que camundongos transplantados com ilhotas encapsuladas secretaram mais insulina do que controles, 60 (LN-Biodritina) ou 100 (PFC- e LN-Biodritina) dias pós-cirurgia. O explante restabeleceu a hiperglicemia nos camundongos. Microcápsulas recuperadas de animais hiperglicêmicos apresentavam uma extensa adesão celular. Testes de secreção de insulina in vitro demonstraram que somente ilhotas do grupo normoglicêmico responderam às variações da concentração de glicose. Conclusão A adição de moléculas bioativas à Biodritina é capaz de diminuir o estresse em ilhotas isoladas e tem o potencial de melhorar a terapia pelo transplante de ilhotas. / Transplantation of microencapsulated islets represents an attractive therapeutical approach to treat type 1 Diabetes Mellitus, accounting for an improved glycemic control and the abolishment of immunosuppressive therapies. However, maintenance of long-term &#946;-cell viability remains a major problem. During islet isolation, the loss of extracellular matrix interactions and the hypoxic conditions thereafter dramatically affect &#946;-cell survival and function. Objective To lessen the burden of islet stress and achieve a better outcome in islet transplantation we tested the addition of perfluorocarbon (PFC) or laminin (LN), molecules associated respectively with oxygenation and cell-cell interaction, to Biodritin, an alginate-based material suitable for cell microencapsulation. Methodology To test the stability of PFC-Biodritin and LN-Biodritin composites, microcapsules were subjected to different stresses (rotational, osmotic, temperature and culture) for 7 and 30 days. To assess biomaterial purity microcapsules were co-incubated with RAW264.7 murine macrophage cell line for 3, 9 and 24h and macrophage activation was detected through mRNA levels of IL-1&#946; and TNF&#945;. Microcapsules were implanted i.p. in mice and retrieved after 7 or 30 days, for biocompatibility analyses. Gene expression at mRNA (bax, bad, bcl-2, bcl-XL, xiap, caspase 3, mcp1/ccl2, hsp70, ldh, insulin 1 and 2) and protein (Bax, Bcl-XL and Xiap) levels, together with Caspase3 activity, were evaluated in islets microencapsulated in PFC- or LN-Biodritin, upon culturing for 48h in normoxic or hypoxic (<2% O2) conditions. Diabetic mice were transplanted with PFC- or LN-Biodritin microencapsulated islets, followed by assessments of body weight, glycemia and graft function by oral glucose tolerance tests (OGTTs). Microencapsulated islets were retrieved from normoglycemic or hyperglycemic mice and biocompatibility analyses of the beads together with a functional assessment of the graft followed. After graft removal, normoglycemic animals had their glycemias monitored to attest the efficacy of the transplanted islets. Results PFC- and LN-Biodritin microcapsules were as stable and biocompatible as Biodritin. For both biomaterials in normoxia and hypoxia a modulation in gene expression was observed in islets associated with a protection against apoptosis. Also, a decreased expression of stress-related genes (mcp1, hsp70) was evidenced. ldh mRNA levels were down-regulated in PFC-Biodritin microencapsulated islets but upregulated in the presence of LN. Increased levels of insulin mRNA were observed. The differences seen in protein expression indicated the same anti-apoptotic pattern. Caspase3 activity was not different between groups. Concerning diabetes reversal experiments, only mice transplanted with LN-Biodritin microencapsulated islets presented a better outcome, with 60% remaining euglycemic at 198 days post-surgery, compared with 9% for the Biodritin group. OGTT showed that mice transplanted with encapsulated islets secreted more insulin than normal mice, 60 (LN-Biodritin) or 100 days (PFC- and LN-Biodritina) posttransplant. Hyperglycemia was achieved after the retrieval of microcapsules showing graft efficacy. Retrieved microcapsules revealed an extensive overgrowth in most beads from hyperglycemic mice. A static glucose stimulated insulin secretion test revealed that only islets from normoglycemic subjects were able to secrete insulin according to glucose concentration. Conclusion- The addition of bioactive molecules to Biodritin may lessen the stress of isolated islets and have the potential to improve islet transplantation therapy.

Duas metodologias que podem ser utilizadas na localização de defeitos em cabos isolados de alta tensão do tipo Oil Filled (OF) foram analisadas. As metodologias descritas têm como princípio a localização de vazamentos de óleo, ou seja, todo defeito seguido de vazamento de óleo poderá ser localizado a partir das mesmas. A primeira metodologia é baseada no congelamento dos cabos OF, com a linha desenergizada, a fim de localizar vazamentos de óleo de cabos OF a partir de 300 litros por mês. A segunda metodologia é baseada na utilização de traços de gás perfluorcarbono Perfluorocarbon Tracer (PFT), através de um sistema montado com equipamentos que permitem realizar a localização de vazamentos de óleo de cabos OF a partir de 100 litros por mês, sem a necessidade de desligamento da linha subterrânea. Esta dissertação propõe algumas melhorias na metodologia do congelamento e apresenta as primeiras experiências de utilização do PFT no Brasil para localização de vazamentos de óleo. / Two methods that can be used to locate faults in Oil Filled (OF) cables were analyzed. The methods described have the principle of oil leak location. All defects followed by oil leakage can be located using the same. The first method is based in OF cables freezing, with the line outage, in order to locate oil leaks from 300 liters per month and above. The second method is based on the use of tracer gas - Perfluorocarbon Tracer (PFT) and devices that allow to perform the location of oil leaks from 100 liters per month, without the need of underground line outage. This paper proposes some improvements for the freezing method and presents the first experiments in Brazil using PFT to locate oil leakage.

Le développement de différentes formes colloïdales pour la thérapie et le diagnostic médical ultrasonore connait un intérêt croissant depuis de nombreuses années. En particulier, les microbulles de perfluorocarbone (PFC) sont des agents de contraste intéressants, car le gaz est un puissant réflecteur des ultrasons. Plus récemment, les gouttelettes de PFC ont été proposées pour de nouvelles applications acoustiques. Suite à une impulsion acoustique, les ultrasons induisent un changement de phase de l’état liquide à l’état gazeux. Ce phénomène est appelé la vaporisation acoustique de gouttelettes. Parallèlement à l’étude de nouvelles applications, le développement de nouvelles techniques de préparation offrant un meilleur contrôle lors de la production, reste un enjeu primordial. Ainsi, de nouvelles méthodes de préparation basées sur des dispositifs membranaires semblent être particulièrement intéressantes. L’objectif de la thèse porte donc sur le développement de nouvelles techniques à membrane pour la formulation de microbulles et de microgouttelettes de taille contrôlée pour des applications en imagerie et thérapie ultrasonore. Dans ce travail, l’émulsification membranaire directe avec un module membranaire de type cross-flow a été utilisé pour la préparation de microbulles stabilisées par des tensioactifs solubles, tandis qu’un module de type microkit a permis l’obtention de microbulles stabilisées par des phospholipides. Dans un second temps, l’émulsification membranaire par prémix a permis de formuler des microgouttelettes de PFC monodispersées. Pour les différentes formes colloïdales préparées, nous avons observé l’influence des paramètres du procédé (pression, débit et contrainte de cisaillement), des paramètres de formulation (molécules stabilisatrices, type de PFC de la phase dispersée) et des paramètres de la membrane (taille des pores) sur la formation des microbulles/ microgouttelettes. Par la suite, la caractérisation acoustique des microbulles/microgouttelettes a montré que ces systèmes présentent les propriétés nécessaires pour être utilisés comme agents de contraste ultrasonores / The development of various colloidal forms for therapy and diagnosis in ultrasound medical present a great interest for many years. In particular, microbubbles of perfluorocarbon (PFC) are interesting as contrast agents because the gas is a high ultrasound reflector. More recently, PFC droplets have been proposed for news acoustic applications. Indeed, after an acoustic pulse, the ultrasound waves induce a phase change from the liquid state to the gaseous state. This phenomenon is called the acoustic vaporization of droplets. In parallel with the study of new applications, the development of new process offering a better control during production, remains a key issue.Thus, the preparation using news methods based on membrane devices seem to be particularly interesting. The aim of the thesis is the development of new membrane process for the formulation of microbubbles and droplets with a size controlled for ultrasound applications in imaging and therapy. In this work, the direct membrane emulsification with a cross-flow membrane module was used for the preparation of microbubbles stabilized by soluble surfactants, while a microkit module allowed to obtain microbubbles stabilized by phospholipids. In a second step, the membrane emulsification by premix allowed to formulate monodispersed droplets of PFC. For the various colloidal forms prepared, we observed the influence of the process parameters (pressure, flow rate and shear stress), the formulation parameters (surfactants, type of PFC of the dispersed phase) and the membrane parameters (pore size) on the formation of microbubbles/droplets. Subsequently, the acoustic characterization of microbubbles/droplets has shown that these systems have the properties to be used as ultrasonic contrast agents

Duas metodologias que podem ser utilizadas na localização de defeitos em cabos isolados de alta tensão do tipo Oil Filled (OF) foram analisadas. As metodologias descritas têm como princípio a localização de vazamentos de óleo, ou seja, todo defeito seguido de vazamento de óleo poderá ser localizado a partir das mesmas. A primeira metodologia é baseada no congelamento dos cabos OF, com a linha desenergizada, a fim de localizar vazamentos de óleo de cabos OF a partir de 300 litros por mês. A segunda metodologia é baseada na utilização de traços de gás perfluorcarbono Perfluorocarbon Tracer (PFT), através de um sistema montado com equipamentos que permitem realizar a localização de vazamentos de óleo de cabos OF a partir de 100 litros por mês, sem a necessidade de desligamento da linha subterrânea. Esta dissertação propõe algumas melhorias na metodologia do congelamento e apresenta as primeiras experiências de utilização do PFT no Brasil para localização de vazamentos de óleo. / Two methods that can be used to locate faults in Oil Filled (OF) cables were analyzed. The methods described have the principle of oil leak location. All defects followed by oil leakage can be located using the same. The first method is based in OF cables freezing, with the line outage, in order to locate oil leaks from 300 liters per month and above. The second method is based on the use of tracer gas - Perfluorocarbon Tracer (PFT) and devices that allow to perform the location of oil leaks from 100 liters per month, without the need of underground line outage. This paper proposes some improvements for the freezing method and presents the first experiments in Brazil using PFT to locate oil leakage.

O transplante de ilhotas microencapsuladas constitui uma alternativa terapêutica interessante para o Diabetes Mellitus tipo 1, permitindo um melhor controle glicêmico e eliminando a necessidade de imunossupressão. Entretanto, a manutenção a longo prazo da viabilidade das células-&#946; ainda é um desafio. No isolamento, a perda da matriz extracelular e as condições hipóxicas subsequentes afetam decisivamente a sobrevivência e funcionalidade das ilhotas. Objetivo Para diminuir o estresse sobre o enxerto, levando a um sucesso prolongado do transplante, propôs-se a adição de perfluorocarbono (PFC) ou laminina (LN), moléculas associadas respectivamente à oxigenação e interações célula-célula, ao biomaterial baseado em alginato, Biodritina, adequado ao encapsulamento celular. Metodologia Para testar a estabilidade das formulações PFC-Biodritina e LN-Biodritina, microcápsulas foram submetidas a diferentes estresses (rotacional, osmótico, temperatura e cultura) por 7 e 30 dias. A pureza do biomaterial foi avaliada pela coincubação com macrófagos murinos RAW264.7, por 3, 9 e 24h, quando a ativação dos macrófagos foi observada pela expressão gênica de IL- 1&#946; e TNF&#945;. Microcápsulas implantadas i.p. em camundongos foram recuperadas após 7 ou 30 dias, para análises de biocompatibilidade. A expressão de níveis de mRNA (bax, bad, bcl-2, bcl-XL, xiap, caspase 3, mcp1/ccl2, hsp70, ldh, insulina 1 e 2), proteínas (Bax, Bcl-XL e Xiap) e a atividade de Caspase3 foram avaliadas em ilhotas microencapsuladas com PFC- e LN-Biodritina, após cultura de 48h em condições de normóxia e hipóxia (<2% O2). Camundongos diabéticos foram transplantados com ilhotas encapsuladas nas diferentes formulações e os animais foram monitorados pelas variações de massa corporal, glicêmicas e pela funcionalidade do enxerto (TOTGs). As ilhotas foram recuperadas de animais normo ou hiperglicêmicos e uma análise de biocompatibilidade das cápsulas foi realizada, assim como a avaliação funcional das células-&#946;. Após o explante, a glicemia dos animais normoglicêmicos foi monitorada para se atestar a eficiência das ilhotas transplantadas. Resultados Microcápsulas de PFC- e LN-Biodritina são tão estáveis e biocompatíveis quanto as de Biodritina. Para ilhotas encapsuladas em ambos os materiais, em normóxia ou hipóxia, observou-se uma modulação gênica que sugere proteção contra apoptose. Adicionalmente, encontrou-se uma diminuição na expressão de genes indicadores de estresse (mcp1, hsp70). Uma diminuição nos níveis de mRNA de ldh foi vista para PFC-Biodritina, mas o oposto foi encontrado para LN-Biodritina. As diferenças encontradas na expressão proteica sugerem o mesmo padrão anti-apoptótico. Caspase3 não foi modulada por nenhum biomaterial. Nos experimentos de transplante, apenas LN-Biodritina levou reversão prolongada do diabetes, com 60% dos animais normoglicêmicos, 198 dias pós-cirurgia, comparado a 9% do grupo Biodritina. O TOTG demonstrou que camundongos transplantados com ilhotas encapsuladas secretaram mais insulina do que controles, 60 (LN-Biodritina) ou 100 (PFC- e LN-Biodritina) dias pós-cirurgia. O explante restabeleceu a hiperglicemia nos camundongos. Microcápsulas recuperadas de animais hiperglicêmicos apresentavam uma extensa adesão celular. Testes de secreção de insulina in vitro demonstraram que somente ilhotas do grupo normoglicêmico responderam às variações da concentração de glicose. Conclusão A adição de moléculas bioativas à Biodritina é capaz de diminuir o estresse em ilhotas isoladas e tem o potencial de melhorar a terapia pelo transplante de ilhotas. / Transplantation of microencapsulated islets represents an attractive therapeutical approach to treat type 1 Diabetes Mellitus, accounting for an improved glycemic control and the abolishment of immunosuppressive therapies. However, maintenance of long-term &#946;-cell viability remains a major problem. During islet isolation, the loss of extracellular matrix interactions and the hypoxic conditions thereafter dramatically affect &#946;-cell survival and function. Objective To lessen the burden of islet stress and achieve a better outcome in islet transplantation we tested the addition of perfluorocarbon (PFC) or laminin (LN), molecules associated respectively with oxygenation and cell-cell interaction, to Biodritin, an alginate-based material suitable for cell microencapsulation. Methodology To test the stability of PFC-Biodritin and LN-Biodritin composites, microcapsules were subjected to different stresses (rotational, osmotic, temperature and culture) for 7 and 30 days. To assess biomaterial purity microcapsules were co-incubated with RAW264.7 murine macrophage cell line for 3, 9 and 24h and macrophage activation was detected through mRNA levels of IL-1&#946; and TNF&#945;. Microcapsules were implanted i.p. in mice and retrieved after 7 or 30 days, for biocompatibility analyses. Gene expression at mRNA (bax, bad, bcl-2, bcl-XL, xiap, caspase 3, mcp1/ccl2, hsp70, ldh, insulin 1 and 2) and protein (Bax, Bcl-XL and Xiap) levels, together with Caspase3 activity, were evaluated in islets microencapsulated in PFC- or LN-Biodritin, upon culturing for 48h in normoxic or hypoxic (<2% O2) conditions. Diabetic mice were transplanted with PFC- or LN-Biodritin microencapsulated islets, followed by assessments of body weight, glycemia and graft function by oral glucose tolerance tests (OGTTs). Microencapsulated islets were retrieved from normoglycemic or hyperglycemic mice and biocompatibility analyses of the beads together with a functional assessment of the graft followed. After graft removal, normoglycemic animals had their glycemias monitored to attest the efficacy of the transplanted islets. Results PFC- and LN-Biodritin microcapsules were as stable and biocompatible as Biodritin. For both biomaterials in normoxia and hypoxia a modulation in gene expression was observed in islets associated with a protection against apoptosis. Also, a decreased expression of stress-related genes (mcp1, hsp70) was evidenced. ldh mRNA levels were down-regulated in PFC-Biodritin microencapsulated islets but upregulated in the presence of LN. Increased levels of insulin mRNA were observed. The differences seen in protein expression indicated the same anti-apoptotic pattern. Caspase3 activity was not different between groups. Concerning diabetes reversal experiments, only mice transplanted with LN-Biodritin microencapsulated islets presented a better outcome, with 60% remaining euglycemic at 198 days post-surgery, compared with 9% for the Biodritin group. OGTT showed that mice transplanted with encapsulated islets secreted more insulin than normal mice, 60 (LN-Biodritin) or 100 days (PFC- and LN-Biodritina) posttransplant. Hyperglycemia was achieved after the retrieval of microcapsules showing graft efficacy. Retrieved microcapsules revealed an extensive overgrowth in most beads from hyperglycemic mice. A static glucose stimulated insulin secretion test revealed that only islets from normoglycemic subjects were able to secrete insulin according to glucose concentration. Conclusion- The addition of bioactive molecules to Biodritin may lessen the stress of isolated islets and have the potential to improve islet transplantation therapy.

No description available.

L’expérience PICO fait partie des chefs de file mondiaux dans la tentative de détection directe de la matière sombre. Cette expérience se spécialise dans l’utilisation des détecteurs à liquide surchauffé pour y parvenir. Le futur détecteur de la collaboration, PICO-500, tentera de détecter les WIMPs (Weakly Interacting Massive Particle) une fois construit dans le laboratoire sous-terrain SNOLAB. Ce détecteur utilisera un mélange de perfluorocarbone comme fluide actif, une nouveauté pour les chambres à bulles. L’utilisation d’un mélange présente des avantages importants dans la conception du détecteur. Celle-ci permettra de diminuer les contraintes d’ingénierie tout en offrant une sensibilité de détection importante. La chambre à bulles PICO-0.1 est utilisée principalement pour la calibration de perfluorocarbone. À l’aide du tandem situé à l’Université de Montréal et d’une cible de vanadium-51, j’ai pu envoyer des neutrons monoénergétiques afin d’évaluer l’énergie de seuil de la formation de bulles dans ce mélange. Le modèle de Seitz décrivant la formation des bulles a été bien étudié dans le cadre de fluide pur, mais pas dans le cas de mélange de perfluorocarbone. Ce type de calibration effectuée avec le détecteur PICO-0.1 nous a permis de confirmer la validité du modèle de Seitz et que les effets du transport de masse peut être négligés pour ce mélange. La vérification de cette hypothèse était cruciale à la compréhension de la dynamique impliquée dans la formation des bulles et nécessaire pour l’utilisation du futur détecteur PICO-500. / The PICO experiment is one of the world’s leading experiments in the effort to directly detect dark matter. This experiment specializes in the use of superheated liquid detectors for that end. The future PICO detector, PICO-500, will attempt to detect WIMPs (Weakly Interacting Massive Particle) once it will be built at the underground laboratory SNOLAB. This detector will use a mixture of perfluorocarbon as an active fluid, a novelty for bubble chambers in dark matter searches. The use of mixture presents important advantages in the design of this detector. This will allow to lessen some of the engineering constraints while still offering a high sensitivity. The PICO-0.1 bubble chamber is mainly used for the calibration of perfluorocarbon. With the help of the Université de Montréal’s tandem and a target of vanadium-51, I was able to send monoenergetic neutrons to evaluate the threshold energy of bubble nucleation of this mixture. The Seitz model describing bubble formation has been widely studied in the context of pure fluid, but not in the case of perfluorocarbon mixture. This type of calibration with PICO-0.1 has allowed us to confirm that the Seitz model still apply and that the effects of mass transport can be neglected for this mixture. The verification of this hypothesis was crucial to the understanding of the dynamics implicated in bubble formation and was necessary for the future use of PICO-500.